ClinVar Miner

Submissions for variant NM_015120.4(ALMS1):c.12111C>G (p.Thr4037=) (rs767174517)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000424951 SCV000533458 uncertain significance not provided 2016-11-04 criteria provided, single submitter clinical testing Although the c.12111 C>G variant is a synonymous change, one splicing algorithm suggests that this nucleotide substitution destroys the natural splice donor site in intron 19, and may lead to abnormal splicing. The c.12111 C>G variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The c.12111 C>G variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. Nonetheless, two other splicing algorithims predict no effect to the natural splice donor site in intron 19. Furthermore, this nucletotide substitution is not conserved across species. Segregation and functional mRNA studies are necessary to clarify the role of this variant in disease.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.